Institutional Sign In

Go

Lekarna.cz

Lekarna.cz's net profit rose 191% yoy to CZK 7.44 mil in 2019

By Helgi Analytics - June 22, 2021

Lekarna.cz made a net profit of CZK 7.44 mil with revenues of CZK 720 mil in 2019, up by 191% and up by 38.9%, resp...

Lekarna.cz's employees remain unchanged yoy at in 2019

By Helgi Analytics - May 6, 2020

Lekarna.cz employed 87.0 employees in 2019, down 5.43% compared to the previous year. Historically, between 2010 and 20...

Lekarna.cz's Net Margin rose 166% yoy to 1.03% in 2019

By Helgi Analytics - June 22, 2021

Lekarna.cz made a net profit of CZK 7.44 mil with revenues of CZK 720 mil in 2019, up by 191% and up by 38.9%, respectively,...

Profit Statement 2017 2018 2019
Sales CZK mil 510 519 720
Gross Profit CZK mil 136 136 64.6
EBITDA CZK mil 6.09 -1.57 16.9
EBIT CZK mil 4.03 -5.56 10.9
Financing Cost CZK mil 0.517 1.18 1.21
Pre-Tax Profit CZK mil 1.99 -7.56 8.23
Net Profit CZK mil 1.83 -8.17 7.44
Balance Sheet 2017 2018 2019
Total Assets CZK mil 138 140 160
Non-Current Assets CZK mil 12.2 23.3 17.9
Current Assets CZK mil 120 113 139
Working Capital CZK mil 37.9 38.0 24.3
Shareholders' Equity CZK mil 31.8 23.5 31.1
Liabilities CZK mil 106 116 129
Total Debt CZK mil 49.0 54.6 32.9
Net Debt CZK mil 25.0 27.7 1.11
Ratios 2017 2018 2019
ROE % 2.33 -29.5 27.3
ROCE % 4.25 -14.7 14.4
Gross Margin % 26.6 26.3 8.97
EBITDA Margin % 1.19 -0.302 2.35
EBIT Margin % 0.789 -1.07 1.51
Net Margin % 0.359 -1.57 1.03
Net Debt/EBITDA 4.10 -17.7 0.066
Net Debt/Equity % 78.4 118 3.58
Cost of Financing % 1.28 2.28 2.76
Cash Flow 2017 2018 2019
Total Cash From Operations CZK mil -13.0 4.11 26.6
Total Cash From Investing CZK mil 0.109 -3.86 0.401
Total Cash From Financing CZK mil 11.7 2.60 -22.2
Net Change In Cash CZK mil -1.11 2.85 4.84
Cash Conversion Cycle days 24.2 20.9 9.65
Cash Earnings CZK mil 3.90 -4.18 13.5
Free Cash Flow CZK mil -12.8 0.249 27.0

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
income statement                            
Sales CZK mil               499 549 474 522 510    
Gross Profit CZK mil               135 148 137 145 136    
EBIT CZK mil               -14.0 -16.6 14.6 7.11 4.03    
Net Profit CZK mil               -15.4 -5.08 10.5 3.24 1.83    
                               
ROE % ...             -37.8 -20.8 14.3 2.59 2.33    
EBIT Margin %               -2.81 -3.02 3.09 1.36 0.789    
Net Margin %               -3.08 -0.926 2.21 0.620 0.359    
Employees ... ... ... ...       125 130 86.0 83.6 90.0    
balance sheet                            
Total Assets CZK mil               139 86.7 125 125 138    
Non-Current Assets CZK mil               16.5 7.40 8.64 11.1 12.2    
Current Assets CZK mil               122 79.1 116 109 120    
                               
Shareholders' Equity CZK mil               27.6 21.3 125 125 31.8    
Liabilities CZK mil               112 65.4 0 0 106    
Non-Current Liabilities CZK mil               0 0 0 0 0    
Current Liabilities CZK mil               78.6 53.2 86.4 79.1 91.0    
                               
Net Debt/EBITDA               0.312 -0.202 0.115 0.754 4.10    
Net Debt/Equity %               -13.9 14.6 1.42 5.10 78.4    
Cost of Financing % ... ... ... ... ... ...   2.08 2.87 2.72 1.54 1.28    
cash flow                            
Total Cash From Operations CZK mil ... ... ... ... ... ... ... ... ... ... -0.562 -13.0    
Total Cash From Investing CZK mil ... ... ... ... ... ... ... ... ... ... -3.75 0.109    
Total Cash From Financing CZK mil ... ... ... ... ... ... ... ... ... ... 0.201 11.7    
Net Change In Cash CZK mil ... ... ... ... ... ... ... ... ... ... -4.11 -1.11    
income statement Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
income statement                            
Sales CZK mil               499 549 474 522 510    
Cost of Goods & Services CZK mil               364 401 337 377 375    
Gross Profit CZK mil               135 148 137 145 136    
Staff Cost CZK mil               59.8 64.1 45.3 44.6 52.2    
EBITDA CZK mil               -12.3 -15.4 15.4 8.46 6.09    
Depreciation CZK mil               1.73 1.19 0.770 1.35 2.06    
EBIT CZK mil               -14.0 -16.6 14.6 7.11 4.03    
Net Financing Cost CZK mil               1.22 2.39 1.43 2.29 -2.04    
Financing Cost CZK mil               0.449 0.513 0.559 0.483 0.517    
Financing Income CZK mil               0.025 0.033 0.207 0.080 0.267    
Pre-Tax Profit CZK mil               -15.4 -4.66 13.2 4.82 1.99    
Tax CZK mil               0 0.420 2.73 1.59 0.159    
Minorities CZK mil               0 0 0 0 0    
Net Profit CZK mil               -15.4 -5.08 10.5 3.24 1.83    
Net Profit Avail. to Common CZK mil               -15.4 -5.08 10.5 3.24 1.83    
growth rates                            
Total Revenue Growth % ...             16.5 9.96 -13.7 10.1 -2.19    
Staff Cost Growth % ...             15.0 7.15 -29.3 -1.57 17.1    
EBITDA Growth % ...             -504 25.2 -200 -45.1 -28.0    
EBIT Growth % ...             -1,162 18.2 -188 -51.4 -43.4    
Pre-Tax Profit Growth % ...             723 -69.7 -383 -63.5 -58.7    
Net Profit Growth % ...             678 -66.9 -306 -69.1 -43.4    
ratios                            
ROE % ...             -37.8 -20.8 14.3 2.59 2.33    
ROA % ...             -10.7 -4.50 9.89 2.59 1.39    
ROCE % ...             -26.8 -12.0 36.3 9.89 4.25    
Gross Margin %               27.0 27.0 28.9 27.7 26.6    
EBITDA Margin %               -2.46 -2.80 3.25 1.62 1.19    
EBIT Margin %               -2.81 -3.02 3.09 1.36 0.789    
Net Margin %               -3.08 -0.926 2.21 0.620 0.359    
Cost of Financing % ... ... ... ... ... ...   2.08 2.87 2.72 1.54 1.28    
Net Debt/EBITDA               0.312 -0.202 0.115 0.754 4.10    
balance sheet Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
balance sheet                            
Cash & Cash Equivalents CZK mil               29.5 6.90 29.3 25.2 24.0    
Receivables CZK mil               47.4 41.3 43.6 46.2 49.3    
Inventories CZK mil               30.1 14.9 23.1 19.3 30.6    
Current Assets CZK mil               122 79.1 116 109 120    
Property, Plant & Equipment CZK mil               11.1 1.20 1.81 0.878 1.34    
LT Investments & Receivables CZK mil               0 0 0 0 0    
Intangible Assets CZK mil               0.536 2.40 4.48 7.48 9.03    
Goodwill CZK mil               0 0 0 0 0    
Non-Current Assets CZK mil               16.5 7.40 8.64 11.1 12.2    
Total Assets CZK mil               139 86.7 125 125 138    
                               
Trade Payables CZK mil               37.5 35.3 46.0 40.5 42.0    
Short-Term Debt CZK mil               25.7 10.0 31.1 31.6 49.0    
Other ST Liabilities CZK mil               15.5 7.89 9.30 7.02 -0.014    
Current Liabilities CZK mil               78.6 53.2 86.4 79.1 91.0    
Long-Term Debt CZK mil               0 0 0 0 0    
Other LT Liabilities CZK mil               0 0 0 0 0    
Non-Current Liabilities CZK mil               0 0 0 0 0    
Liabilities CZK mil               112 65.4 0 0 106    
Equity Before Minority Interest CZK mil               27.6 21.3 125 125 31.8    
Minority Interest CZK mil               0 0 0 0 0    
Equity CZK mil               27.6 21.3 125 125 31.8    
growth rates                            
Total Asset Growth % ...             -6.61 -37.7 44.2 0.097 9.99    
Shareholders' Equity Growth % ...             -48.5 -22.9 487 0.097 -74.6    
Net Debt Growth % ...             -30.6 -181 -42.7 259 291    
Total Debt Growth % ... ... ... ... ... ... ... 46.9 -61.1 211 1.58 55.1    
ratios                            
Total Debt CZK mil               25.7 10.0 31.1 31.6 49.0    
Net Debt CZK mil               -3.83 3.10 1.78 6.38 25.0    
Working Capital CZK mil               40.1 20.9 20.7 24.9 37.9    
Capital Employed CZK mil               56.6 28.3 29.4 36.0 50.2    
Net Debt/Equity %               -13.9 14.6 1.42 5.10 78.4    
Current Ratio               1.55 1.49 1.34 1.38 1.32    
Quick Ratio               0.979 0.905 0.844 0.902 0.806    
cash flow Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
cash flow                            
Net Profit CZK mil               -15.4 -5.08 10.5 3.24 1.83    
Depreciation CZK mil               1.73 1.19 0.770 1.35 2.06    
Non-Cash Items CZK mil ... ... ... ... ... ... ... ... ... ... -0.962 -3.83    
Change in Working Capital CZK mil ... ... ... ... ... ... ... ... ... ... -4.19 -13.0    
Total Cash From Operations CZK mil ... ... ... ... ... ... ... ... ... ... -0.562 -13.0    
                               
Capital Expenditures CZK mil ... ... ... ... ... ... ... ... ... ... -3.85 -4.97    
Other Investing Activities CZK mil ... ... ... ... ... ... ... ... ... ... 0.099 5.08    
Total Cash From Investing CZK mil ... ... ... ... ... ... ... ... ... ... -3.75 0.109    
                               
Dividends Paid CZK mil ... ... ... ... ... ... ... ... ... ... 0 -5.42    
Issuance Of Shares CZK mil ... ... ... ... ... ... ... ... ... ... 0 0    
Issuance Of Debt CZK mil ... ... ... ... ... ... ... ... ... ... 0.490 17.2    
Total Cash From Financing CZK mil ... ... ... ... ... ... ... ... ... ... 0.201 11.7    
                               
Effect of FX Rates CZK mil ... ... ... ... ... ... ... ... ... ... ... 0    
Net Change In Cash CZK mil ... ... ... ... ... ... ... ... ... ... -4.11 -1.11    
ratios                            
Days Sales Outstanding days               34.7 27.4 33.6 32.3 35.3    
Days Sales Of Inventory days               30.2 13.6 25.0 18.6 29.8    
Days Payable Outstanding days               37.5 32.2 49.8 39.2 40.9    
Cash Conversion Cycle days               27.3 8.88 8.83 11.7 24.2    
Cash Earnings CZK mil               -13.6 -3.89 11.2 4.59 3.90    
Free Cash Flow CZK mil ... ... ... ... ... ... ... ... ... ... -4.31 -12.8    
Capital Expenditures (As % of Sales) % ... ... ... ... ... ... ... ... ... ... 0.738 0.973    
other ratios Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
                             
Employees ... ... ... ...       125 130 86.0 83.6 90.0    
Cost Per Employee USD per month ... ... ... ...       2,039 1,923 1,840 1,763 2,059   ...
Cost Per Employee (Local Currency) CZK per month ... ... ... ...       39,891 41,097 43,913 44,471 48,355    
Staff Cost (As % of Sales) %               12.0 11.7 9.56 8.55 10.2    
Effective Tax Rate %               0 -9.01 20.7 32.9 7.99    
Total Revenue Growth (5-year average) % ... ... ... ... ...     18.8 17.2 10.4 7.72 3.56    
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ... 18.7 13.2    

Get all company financials in excel:

Download Sample   $19.99

Lekarna.cz's ROCE rose 198% yoy to 14.4% in 2019

By Helgi Analytics - June 22, 2021

Lekarna.cz made a net profit of CZK 7.44 mil in 2019, up 191% compared to the previous year. Historically, between 2006 and 2019, the company's net profit reached a high of CZK 16.1 mil in 2010 and a low of CZK -15.4 mil in 2013. The result implies a retu...

Lekarna.cz's Net Debt/EBITDA rose 100% yoy to 0.066 in 2019

By Helgi Analytics - June 22, 2021

Lekarna.cz's net debt stood at CZK 1.11 mil and accounted for 3.58% of equity at the end of 2019. The ratio is down 114 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of ...

More News

Lekarna.cz is a Czech-based online pharmacy owned by Pears Health Cyber. The Company was set up by Vladimír Finsterle in 1999 as an information portal about medications. In 2003, the Company turned into an e-shop and become the first online pharmacy in the Czech Republic.

Lekarna.cz Logo

Finance

Lekarna.cz has been growing its sales by 5.59% a year on average in the last 5 years. EBITDA has grown by 210% during that time to total of CZK 16.9 mil in 2019, or 2.35% of sales. That’s compared to 1.62% average margin seen in last five years.

The company netted CZK 7.44 mil in 2019 implying ROE of 27.3% and ROCE of 14.4%. Again, the average figures were 3.39% and 10.0%, respectively when looking at the previous 5 years.

Lekarna.cz’s net debt amounted to CZK 1.11 mil at the end of 2019, or 3.58% of equity. When compared to EBITDA, net debt was 0.066x, up when compared to average of -2.53x seen in the last 5 years.